Berindan-Neagoe I - Search Results

1

Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania.

Frinc I, Ilies P, Zaharie F, Dima D, Tanase A, Petrov L, Irimie A, Berce C, Lisencu C, Berindan-Neagoe I, Tomuleasa C, Bojan A. Frinc I, et al. Rom J Intern Med. 2017 Jun 1;55(2):103-116. doi: 10.1515/rjim-2017-0006. Rom J Intern Med. 2017. PMID: 28103204 Free article.

2

Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.

Burz C, Berindan-Neagoe IB, Balacescu O, Tanaselia C, Ursu M, Gog A, Vlase L, Chintoanu M, Balacescu L, Leucuta SE, Irimie A, Cristea V. Burz C, et al. J Gastrointestin Liver Dis. 2009 Mar;18(1):39-43. J Gastrointestin Liver Dis. 2009. PMID: 19337632 Free article. Clinical Trial.

3

Apoptosis in cancer: key molecular signaling pathways and therapy targets.

Burz C, Berindan-Neagoe I, Balacescu O, Irimie A. Burz C, et al. Acta Oncol. 2009;48(6):811-21. doi: 10.1080/02841860902974175. Acta Oncol. 2009. PMID: 19513886 Review.

4

Oxaliplatin in patients with metastatic colorectal cancer: efficacy and pharmacokinetics parameters.

Burz C, Berindan-Neagoe I, Balacescu O, Todor N, Pelau D, Floares C, Kacso G, Tanaselia C, Ursu M, Vlase L, Leucuta SE, Cristea V, Irimie A. Burz C, et al. J BUON. 2010 Apr-Jun;15(2):263-9. J BUON. 2010. PMID: 20658719

5

The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer.

Ionescu C, Berindan-Neagoe I, Burz C, Balacescu O, Balacescu L, Tudoran O, Asztalos R, Irimie A. Ionescu C, et al. J BUON. 2011 Apr-Jun;16(2):274-6. J BUON. 2011. PMID: 21766497

6

Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data.

Berindan-Neagoe I, Chiorean R, Braicu C, Florian IS, Leucuta D, Crisan D, Cocis A, Balacescu O, Irimie A. Berindan-Neagoe I, et al. Eur Cytokine Netw. 2012 Jun;23(2):45-55. doi: 10.1684/ecn.2012.0302. Eur Cytokine Netw. 2012. PMID: 22591734 Free article.

7

Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways.

Berindan-Neagoe I, Braicu C, Tudoran O, Balacescu O, Irimie A. Berindan-Neagoe I, et al. J Nanosci Nanotechnol. 2012 Mar;12(3):2113-9. doi: 10.1166/jnn.2012.5701. J Nanosci Nanotechnol. 2012. PMID: 22755028

8

Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects.

Berindan-Neagoe I, Braicu C, Irimie A. Berindan-Neagoe I, et al. Int J Nanomedicine. 2012;7:6035-47. doi: 10.2147/IJN.S36523. Epub 2012 Dec 12. Int J Nanomedicine. 2012. PMID: 23251091 Free PMC article.

9

Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.

Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Braicu C, et al. J Nanosci Nanotechnol. 2013 Jan;13(1):632-7. doi: 10.1166/jnn.2013.6882. J Nanosci Nanotechnol. 2013. PMID: 23646788

10

The relationship between the structure and biological actions of green tea catechins.

Braicu C, Ladomery MR, Chedea VS, Irimie A, Berindan-Neagoe I. Braicu C, et al. Food Chem. 2013 Dec 1;141(3):3282-9. doi: 10.1016/j.foodchem.2013.05.122. Epub 2013 Jun 4. Food Chem. 2013. PMID: 23871088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters